What is Fluticasone furoate-Vilanterol?

Category: Prescription Drugs

Most popular types: Breo Ellipta Relvar Ellipta

false

Fluticasone-Vilanterol is a combination inhaled corticosteroid and long-acting beta-2-adrenergic agonists. It is used to treat airflow obstruction in patients with chronic obstructive pulmonary disease.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Asthma 58 29
Chronic obstructive pulmonary disease 26 12
Wheezing 5 3
Breathing difficulty 1 0
Bronchitis 1 1
Chronic cough 1 0

Show all 12 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 2
Mild 5
None 37

Commonly reported side effects and conditions associated with Fluticasone furoate-Vilanterol

Side effect Patients Percentage
Anxious mood 1
Chronic belching 1
Dry mouth 1
Elevated blood sugar (hyperglycemia) 1
Excessive dry mouth 1
Increased anxiety 1

Show all 10 reported side effects

Dosages

Based on patients currently taking Fluticasone furoate-Vilanterol

Dosage Patients Percentage
100-25 mcg/puff daily 7
200-25 mcg/puff daily 3
1 other daily 1
100 mcg daily 1
100-25mcg/puff as needed 1

Why patients stopped taking Fluticasone furoate-Vilanterol

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 6
Did not seem to work 5
Change in health plan coverage 2
Course of treatment ended 1
Expense 1
Other 1
Side effects too severe 1
See all 15 patients who've stopped taking Fluticasone furoate-Vilanterol

Duration

Currently taking Fluticasone furoate-Vilanterol

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 3
2 - 5 years 8

Stopped taking Fluticasone furoate-Vilanterol

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 4
6 months - 1 year 2
1 - 2 years 1
2 - 5 years 5
5 - 10 years 1
Adherence
Adherence Evaluations Percentage
Always 29
Usually 16
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 1
A little hard to take 10
Not at all hard to take 33
Cost per month
Cost per month Evaluations Percentage
$200+ 3
$100-199 0
$50-99 3
$25-49 6
< $25 13
Not specified 20

What people switch to and from

Patients started taking Fluticasone furoate-Vilanterol after stopping:

Treatment Patients Percentage
Fluticasone-Salmeterol (Advair Diskus) 9
Budesonide-Formoterol (Symbicort) 8
Albuterol (Albuterol Inhaler) 5
Tiotropium inhaler (Spiriva HandiHaler) 4
Budesonide (Pulmicort) 2

Show all 11 treatments patients report switching from

Patients stopped taking Fluticasone furoate-Vilanterol and switched to:

Treatment Patients Percentage
Fluticasone-Salmeterol (Advair Diskus) 5
Fluticasone-Umeclidinium-Vilanterol (Trelegy Ellipta) 2
Albuterol (Albuterol Inhaler) 1
Budesonide-Formoterol (Symbicort) 1
Olodaterol-Tiotropium (Stiolto Respimat) 1

Show all 7 treatments patients report switching to

Last updated:

2 patient evaluations for Fluticasone furoate-Vilanterol

Mar 15, 2019 (Started Dec 15, 2016)

  • Effectiveness
    Slight (for asthma)
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 200-25 mcg/puff Daily

Feb 7, 2019 (Started Dec 15, 2016)

  • Effectiveness
    Slight (for asthma)
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 200-25 mcg/puff Daily
Advice & Tips: Switched to Advair because dividing my daily dose in half and taking it morning and evening might give me better relief.

Apr 15, 2017 (Started Dec 15, 2016)

  • Effectiveness
    Slight (for asthma)
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 200-25 mcg/puff Daily
Advice & Tips: I had hoped for more relief than it has provided. Important to remember to wash out my mouth after using to prevent developing thrush. It does help my breathing some which helps my energy levels some, too.

  • 0 helpful marks

Aug 13, 2018 (Started Jul 01, 2015)

  • Effectiveness
    None (for chronic obstructive pulmonary disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Fluticasone furoate-Vilanterol